The AI Doc: Or How I Became an Apocaloptimist seeks the middle ground on a polarizing technology—and ends up letting tech execs like Sam Altman off the hook.
A policy change announced by NeurIPS, the world’s leading AI research conference, drew widespread backlash from Chinese researchers this week and then was quickly reversed.
Ads are rolling out across the US on ChatGPT’s free tier. I asked OpenAI’s bot 500 questions to see what these ads were like and how they related to my prompts.
0 Comments